From the Archives: Mapping Directions for Diabetes Research
A historical account about a past initiative that would help pave the way for Breakthrough T1D’s future approach to identifying research priorities.
Dr. Jane Buckner Discusses Hydroxychloroquine T1D Prevention Study
Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.
Viacyte Receives Funding to Continue Developing Beta Cell Therapies
ViaCyte, a regenerative medicine company long-supported by Breakthrough T1D, today announced $27 million in financing to continue the development of beta cell therapies for diabetes. This funding ensures that Viacyte’s innovative approaches to replacing the insulin-producing beta cells in people with type 1 diabetes (T1D) will keep progressing. “Beta cell therapies are a key component […]
Breakthrough T1D Heads, Virtually, to ADA’s 80th Scientific Sessions
The American Diabetes Association’s (ADA) 80th Scientific Sessions is almost here! From June 12-16, scientists and healthcare professionals will gather, virtually, at one of the largest conferences of diabetes researchers in the world. Breakthrough T1D-funded researchers will also be there virtually to hear first-hand and present new study results that will improve outcomes for people […]
Medtronic Panel Discusses Supporting T1D Community During COVID-19
During a recent Breakthrough T1D Facebook Live event, a panel of leaders discussed Medtronic’s efforts to support the T1D community during the pandemic.
Meet the Scientist: Local Immune Suppression with a Novel Protein
Mark Poznansky, M.D., Ph.D., wants the seemingly impossible—a person with type 1 diabetes (T1D) has a procedure where beta cells are placed in their body, the doctor stitches it up and the person has functioning insulin-producing beta cells, for life. Of course, we’re not there yet, but, with Dr. Poznansky—and many, many other researchers—Breakthrough T1D […]
Improving the Lives of Veterans With Diabetes
How to access the latest diabetes management tools through the Department of Veterans Affairs with Armed For Diabetes .
A Promising (Preclinical) Vaccine for Type 1 Diabetes
Wouldn’t it be nice if you could take a vaccine in infancy, and type 1 diabetes would not develop? Preclinical research suggests it might not be that far away.
Dr. Carla Greenbaum Talks about T1D TrialNet During the COVID-19 Pandemic
Carla Greenbaum, M.D., chair of TrialNet—an international Breakthrough T1D-supported network that is dedicated to finding cures for type 1 diabetes (T1D)—and a professor at Benaroya Research Institute, discussed T1D research in the time of COVID-19, including what TrialNet is up to, on Breakthrough T1D’s Facebook Live event. She chats about: What do we know now […]
Breakthrough T1D Plays a Leadership Role, Again, to Marshal Resources for T1D Research
It’s 2004. The California Institute for Regenerative Medicine (CIRM), which will fund $3 billion in stem cell research to advances new therapies, is on the ballot, if it gets approved. Fortunately, the patients, families and scientists were the voices that day, with nearly 60% voting to approve it. In the time since 2004, it has […]
